Similar articles

• The effect of fenfluramine on obese, maturity-onset diabetic patients.

  Wales JK. Wales JK. Acta Endocrinol (Copenh). 1979 Apr;90(4):616-23. doi: 10.1530/acta.0.0900616. Acta Endocrinol (Copenh). 1979. PMID: 373358 Clinical Trial.
• The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics.

  Dykes JR. Dykes JR. Postgrad Med J. 1973 May;49(571):318-24. doi: 10.1136/pgmj.49.571.318. Postgrad Med J. 1973. PMID: 4804456 Free PMC article. Clinical Trial.
• Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.

  Pontiroli AE, Pacchioni M, Piatti PM, Cassisa C, Camisasca R, Pozza G. Pontiroli AE, et al. J Clin Endocrinol Metab. 1996 Oct;81(10):3727-32. doi: 10.1210/jcem.81.10.8855830. J Clin Endocrinol Metab. 1996. PMID: 8855830 Clinical Trial.
• Aspects of the pathogenesis of type 2 diabetes.

  Efendić S, Luft R, Wajngot A. Efendić S, et al. Endocr Rev. 1984 Summer;5(3):395-410. doi: 10.1210/edrv-5-3-395. Endocr Rev. 1984. PMID: 6381035 Review. No abstract available.
• [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].

  Vague P, Vague J. Vague P, et al. Journ Annu Diabetol Hotel Dieu. 1972;13(0):55-65. Journ Annu Diabetol Hotel Dieu. 1972. PMID: 4605752 Review. French. No abstract available.